NCT01107262

Brief Summary

The highly pathogenic avian influenza (HPAI) H5N1 virus arrived in the Middle East in 2005 and has since established itself in local domestic birds and is now considered endemic in several Middle Eastern countries.Few studies indicate the presence of low pathogenicity avian influenza (LPAI) viruses of the H9 type among Lebanese poultry and wild birds. These studies also provide some evidence suggesting that humans exposed to these sick birds are showing elevated antibody titers against these LPAI H9 viruses. This study will focus on the following objectives:

  • To determine the seroprevalence of AI in poultry-exposed and non-exposed human populations.
  • To identify risk factors associated with AI infections in occupationally-exposed poultry workers.
  • To conduct nation-wide cross-sectional surveillance for AI viruses among domestic birds in low biosecurity farms and backyard flocks.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2009

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 20, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

October 27, 2011

Status Verified

October 1, 2011

Enrollment Period

1.4 years

First QC Date

April 19, 2010

Last Update Submit

October 26, 2011

Conditions

Keywords

H5N1 SubtypeAvian virusesHighly pathogenic avian influenza (HPAI)

Outcome Measures

Primary Outcomes (3)

  • The seroprevalence of Avian Influenza in poultry-exposed and non-exposed human populations.

    1 year

  • Risk factors associated with AI infections in occupationally-exposed poultry workers.

    1 year

  • Nation-wide cross-sectional surveillance for AI viruses among domestic birds in low biosecurity farms and backyard flocks.

    1 year

Study Arms (2)

Poultry exposed adults

This seroepidemiological study proposes to compare adults with occupational exposure to poultry with non-poultry exposed adult controls for evidence of previous infections with AI viruses.In this study, any person with occupational exposure to poultry i.e. works in poultry production facility or raises a smaller number of poultry on his/her farm will be considered exposed. The questionnaire used in this study will capture poultry exposure data through a group of variables assessing type of occupational setting, length of time of exposure, flock size, type of work performed, and personal protective equipment (PPE) used.

Poultry Non-exposed Adult Controls

Controls, adults who were never exposed to poultry, will be enrolled from urban areas such as the capital Beirut. Controls will be invited to volunteer by word of mouth at public/community sites.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will be conducted in the rural areas of Lebanon where poultry production is located.Specifically, three main regions will be included in this study, the Beqaa, North Lebanon, and South Lebanon regions.The Mount Lebanon and Beirut regions are heavily urbanized and poultry production in these regions is minimal.Poultry-exposed individuals will be enrolled according to the following scheme:100 from Beqaa, 50 from North Lebanon, and 50 from South Lebanon. The 50 non-exposed individuals will be enrolled from Beirut. Villages will be randomly selected from each of the 3 regions where enrollment will occur.Each village will be assigned a number and then a random digit sheet will be generated and used to randomly select villages. Controls, adults who were never exposed to poultry, will be enrolled from urban areas such as the capital Beirut. Controls will be invited to volunteer by word of mouth at public/community sites.

You may qualify if:

  • Be at least 18 years old.
  • Be willing to participate by signing a consent form, completing the study questionnaire, and providing a blood sample.

You may not qualify if:

  • Less than 18 years old.
  • Any known immunosuppressive condition or immune deficiency disease (including HIV infection), or ongoing receipt of any immunosuppressive therapy. (Note that we have chosen to exclude such populations because of their increased risk of acquiring infections, they are relatively few, and are not representative of a national sample).
  • Any individual with unknown poultry exposure status, or who was exposed to poultry more than 5 years ago.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

American University of Beirut

Beirut, Beyrouth, 1107-2020, Lebanon

Location

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

A trained phlebotomist will collect a tube of blood (7.5ml) in serum separator tubes. The blood will be allowed to clot at room temperature then centrifuged on the same day. Serum specimens will be aliqouted into multiple cryovials, labelled and preserved at -20°C until ready for laboratory study.

MeSH Terms

Conditions

Influenza in BirdsVirus Diseases

Condition Hierarchy (Ancestors)

Orthomyxoviridae InfectionsRNA Virus InfectionsInfectionsBird DiseasesAnimal Diseases

Study Officials

  • Mohammad Ghazi Kayali, Ph.D, MPH

    St. Jude Children's Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2010

First Posted

April 20, 2010

Study Start

July 1, 2009

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

October 27, 2011

Record last verified: 2011-10

Locations